Shahid Mahmood , Muhammad Waheed Iqbal , Abdullah Arsalan , Xinrui Tang , Yuvaraj Ravikumar , Mei Zhao , Cunsheng Zhang , Xianghui Qi
{"title":"利用共同表达的 L-阿拉伯糖和 L-核糖异构酶提高 L-核糖的生物合成能力","authors":"Shahid Mahmood , Muhammad Waheed Iqbal , Abdullah Arsalan , Xinrui Tang , Yuvaraj Ravikumar , Mei Zhao , Cunsheng Zhang , Xianghui Qi","doi":"10.1016/j.bej.2024.109594","DOIUrl":null,"url":null,"abstract":"<div><div>L-Ribose is an essential rare sugar used in several industries, including pharmaceutical, food, cosmetics, and agriculture. Recently, the enzymatic production of L-ribose has garnered significant attention due to its considerable advantages over synthetic methods. This study introduces a novel approach for producing L-ribose from L-arabinose. Initially, the genes encoding L-arabinose isomerase (L-AI) from <em>Bacillus subtilis</em> str. 168 (BsL-AI) and L-ribose isomerase (L-RI) from <em>Actinotalea fermentans</em> ATCC 43279 (AfL-RI) were cloned to construct the recombinant plasmid containing the pANY1-BsL-AI/AfL-RI vector and co-expressed in <em>Escherichia coli</em> BL21(DE3). Subsequently, the of co-expression exhibited optimal activity at pH 8.5 and 40 °C in 50 mM Tris-HCl buffer, with 1 mM Mn<sup>2+</sup> ion. The activity was increased by 33 % and 12 % with Mn<sup>2+</sup> and Co<sup>2+</sup> ions, respectively, compared to the control having no metal ions. The scheme comprising 50 g L<sup>−1</sup> of co-expressed cells remained comparatively stable up to 60 °C for 2 h. Finally, the co-expression scheme produced 23.52 g L<sup>−1</sup> (24 %), 25.87 g L<sup>−1</sup> (26 %) and 27.97 g L<sup>−1</sup> (28 %) of L-ribose when utilizing L-arabinose concentration of 30, 50 and 100 g L<sup>−1</sup>, respectively, with 50 g L<sup>−1</sup> of co-expressed cells. This study presents a viable methodology for the utilization of L-arabinose to produce L-ribose in slightly alkaline conditions utilizing a co-expression scheme concealing BsL-AI and AfL-RI genes.</div></div>","PeriodicalId":8766,"journal":{"name":"Biochemical Engineering Journal","volume":"215 ","pages":"Article 109594"},"PeriodicalIF":3.7000,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Harnessing co-expressed L-arabinose and L-ribose isomerases to enhance the biosynthesis of L-ribose\",\"authors\":\"Shahid Mahmood , Muhammad Waheed Iqbal , Abdullah Arsalan , Xinrui Tang , Yuvaraj Ravikumar , Mei Zhao , Cunsheng Zhang , Xianghui Qi\",\"doi\":\"10.1016/j.bej.2024.109594\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>L-Ribose is an essential rare sugar used in several industries, including pharmaceutical, food, cosmetics, and agriculture. Recently, the enzymatic production of L-ribose has garnered significant attention due to its considerable advantages over synthetic methods. This study introduces a novel approach for producing L-ribose from L-arabinose. Initially, the genes encoding L-arabinose isomerase (L-AI) from <em>Bacillus subtilis</em> str. 168 (BsL-AI) and L-ribose isomerase (L-RI) from <em>Actinotalea fermentans</em> ATCC 43279 (AfL-RI) were cloned to construct the recombinant plasmid containing the pANY1-BsL-AI/AfL-RI vector and co-expressed in <em>Escherichia coli</em> BL21(DE3). Subsequently, the of co-expression exhibited optimal activity at pH 8.5 and 40 °C in 50 mM Tris-HCl buffer, with 1 mM Mn<sup>2+</sup> ion. The activity was increased by 33 % and 12 % with Mn<sup>2+</sup> and Co<sup>2+</sup> ions, respectively, compared to the control having no metal ions. The scheme comprising 50 g L<sup>−1</sup> of co-expressed cells remained comparatively stable up to 60 °C for 2 h. Finally, the co-expression scheme produced 23.52 g L<sup>−1</sup> (24 %), 25.87 g L<sup>−1</sup> (26 %) and 27.97 g L<sup>−1</sup> (28 %) of L-ribose when utilizing L-arabinose concentration of 30, 50 and 100 g L<sup>−1</sup>, respectively, with 50 g L<sup>−1</sup> of co-expressed cells. This study presents a viable methodology for the utilization of L-arabinose to produce L-ribose in slightly alkaline conditions utilizing a co-expression scheme concealing BsL-AI and AfL-RI genes.</div></div>\",\"PeriodicalId\":8766,\"journal\":{\"name\":\"Biochemical Engineering Journal\",\"volume\":\"215 \",\"pages\":\"Article 109594\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-11-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical Engineering Journal\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1369703X24003814\",\"RegionNum\":3,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical Engineering Journal","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1369703X24003814","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
L- 核糖是一种重要的稀有糖类,可用于制药、食品、化妆品和农业等多个行业。最近,酶法生产 L-核糖因其相对于合成方法的巨大优势而备受关注。本研究介绍了一种从 L-阿拉伯糖生产 L-核糖的新方法。首先,克隆了枯草芽孢杆菌(Bacillus subtilis str. 168)的 L-阿拉伯糖异构酶(L-AI)(BsL-AI)和放线菌(Actinotalea fermentans ATCC 43279)的 L-核糖异构酶(L-RI)(AfL-RI)的编码基因,构建了含有 pANY1-BsL-AI/AfL-RI 载体的重组质粒,并在大肠杆菌 BL21(DE3)中共同表达。随后,在 pH 值为 8.5、温度为 40 ℃、含有 1 mM Mn2+ 离子的 50 mM Tris-HCl 缓冲液中,共同表达的质粒表现出最佳活性。与不含金属离子的对照组相比,含 Mn2+ 和 Co2+ 离子的活性分别提高了 33% 和 12%。由 50 g L-1 的共表达细胞组成的方案在 60 °C 下 2 小时内保持相对稳定。最后,当利用 L-阿拉伯糖浓度分别为 30、50 和 100 g L-1 时,共表达方案与 50 g L-1 的共表达细胞分别产生了 23.52 g L-1 (24%)、25.87 g L-1 (26%)和 27.97 g L-1 (28%)的 L-核糖。本研究提出了一种可行的方法,利用隐藏 BsL-AI 和 AfL-RI 基因的共表达方案,在微碱性条件下利用 L-阿拉伯糖生产 L-核糖。
Harnessing co-expressed L-arabinose and L-ribose isomerases to enhance the biosynthesis of L-ribose
L-Ribose is an essential rare sugar used in several industries, including pharmaceutical, food, cosmetics, and agriculture. Recently, the enzymatic production of L-ribose has garnered significant attention due to its considerable advantages over synthetic methods. This study introduces a novel approach for producing L-ribose from L-arabinose. Initially, the genes encoding L-arabinose isomerase (L-AI) from Bacillus subtilis str. 168 (BsL-AI) and L-ribose isomerase (L-RI) from Actinotalea fermentans ATCC 43279 (AfL-RI) were cloned to construct the recombinant plasmid containing the pANY1-BsL-AI/AfL-RI vector and co-expressed in Escherichia coli BL21(DE3). Subsequently, the of co-expression exhibited optimal activity at pH 8.5 and 40 °C in 50 mM Tris-HCl buffer, with 1 mM Mn2+ ion. The activity was increased by 33 % and 12 % with Mn2+ and Co2+ ions, respectively, compared to the control having no metal ions. The scheme comprising 50 g L−1 of co-expressed cells remained comparatively stable up to 60 °C for 2 h. Finally, the co-expression scheme produced 23.52 g L−1 (24 %), 25.87 g L−1 (26 %) and 27.97 g L−1 (28 %) of L-ribose when utilizing L-arabinose concentration of 30, 50 and 100 g L−1, respectively, with 50 g L−1 of co-expressed cells. This study presents a viable methodology for the utilization of L-arabinose to produce L-ribose in slightly alkaline conditions utilizing a co-expression scheme concealing BsL-AI and AfL-RI genes.
期刊介绍:
The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.
The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:
Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics
Biosensors and Biodevices including biofabrication and novel fuel cell development
Bioseparations including scale-up and protein refolding/renaturation
Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cells
Bioreactor Systems including characterization, optimization and scale-up
Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization
Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticals
Biomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release
Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites
Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation
Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis
Protein Engineering including enzyme engineering and directed evolution.